# EO4010 in Previously Treated Metastatic Colorectal Carcinoma

> **NCT05589597** · PHASE1,PHASE2 · TERMINATED · sponsor: **Enterome** · enrollment: 25 (actual)

## Conditions studied

- Colorectal Cancer Metastatic

## Interventions

- **DRUG:** EO4010

## Key facts

- **NCT ID:** NCT05589597
- **Lead sponsor:** Enterome
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2023-06-01
- **Primary completion:** 2025-05-30
- **Final completion:** 2025-05-30
- **Target enrollment:** 25 (ACTUAL)
- **Why stopped:** Sponsor decision to stop recruitment in context of overall EO4010 development goals. Stop of recruitment was not related to any safety concern, with the safety profile of EO4010 being benign
- **Last updated:** 2025-08-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05589597

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05589597, "EO4010 in Previously Treated Metastatic Colorectal Carcinoma". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT05589597. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*